PMC:7652766 / 80518-80770 2 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T394 | 0-252 | Sentence | denotes | A randomized phase I/II trial studied the infusions of CYNK-001 cells, an allogeneic off-the-shelf cell therapy enriched for CD56+/CD3- NK cells expanded from human placental CD34+ cells in 86 hospitalized patients with moderate COVID-19 disease (283). |